Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling.

作者: Andrew M. Kidger , Linda K. Rushworth , Julia Stellzig , Jane Davidson , Christopher J. Bryant

DOI: 10.1073/PNAS.1614684114

关键词:

摘要: Deregulated extracellular signal-regulated kinase (ERK) signaling drives cancer growth. Normally, ERK activity is self-limiting by the rapid inactivation of upstream kinases and delayed induction dual-specificity MAP phosphatases (MKPs/DUSPs). However, interactions between these feedback mechanisms are unclear. Here we show that, although MKP DUSP5 both inactivates anchors in nucleus, it paradoxically increases prolongs cytoplasmic activity. The latter effect caused, at least part, relief ERK-mediated RAF inhibition. importance this spatiotemporal interaction distinct illustrated fact that expression oncogenic BRAFV600E, a feedback-insensitive mutant kinase, reprograms into cell-wide inhibitor facilitates cell proliferation transformation. In contrast, deletion causes BRAFV600E-induced hyperactivation cellular senescence. Thus, within pathway can regulate transformation, suggest oncogene-specific roles for controlling fate.

参考文章(57)
Srinivasa Subramaniam, Klaus Unsicker, ERK and cell death: ERK1/2 in neuronal death. FEBS Journal. ,vol. 277, pp. 22- 29 ,(2010) , 10.1111/J.1742-4658.2009.07367.X
L. A. Groom, A. A. Sneddon, D. R. Alessi, S. Dowd, S. M. Keyse, Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. The EMBO Journal. ,vol. 15, pp. 3621- 3632 ,(1996) , 10.1002/J.1460-2075.1996.TB00731.X
Christopher J. Caunt, Matthew J. Sale, Paul D. Smith, Simon J. Cook, MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road Nature Reviews Cancer. ,vol. 15, pp. 577- 592 ,(2015) , 10.1038/NRC4000
Véronique Volmat, Jacques Pouysségur, Steve Arkinstall, Philippe Lenormand, Montserrat Camps, The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases Journal of Cell Science. ,vol. 114, pp. 3433- 3443 ,(2001) , 10.1242/JCS.114.19.3433
Seyedmehdi Shojaee, Rebecca Caeser, Maike Buchner, Eugene Park, Srividya Swaminathan, Christian Hurtz, Huimin Geng, Lai N. Chan, Lars Klemm, Wolf-Karsten Hofmann, Yi Hua Qiu, Nianxiang Zhang, Kevin R. Coombes, Elisabeth Paietta, Jeffery Molkentin, H. Phillip Koeffler, Cheryl L. Willman, Stephen P. Hunger, Ari Melnick, Steven M. Kornblau, Markus Müschen, Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia Cancer Cell. ,vol. 28, pp. 114- 128 ,(2015) , 10.1016/J.CCELL.2015.05.008
Christopher J. Caunt, Stephen M. Keyse, Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. FEBS Journal. ,vol. 280, pp. 489- 504 ,(2013) , 10.1111/J.1742-4658.2012.08716.X
J. Zhu, D. Woods, M. McMahon, J. M. Bishop, Senescence of human fibroblasts induced by oncogenic Raf Genes & Development. ,vol. 12, pp. 2997- 3007 ,(1998) , 10.1101/GAD.12.19.2997
Evanthia Diamanti-Kandarakis, Andrea Dunaif, Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications Endocrine Reviews. ,vol. 33, pp. 981- 1030 ,(2012) , 10.1210/ER.2011-1034
Anne Brunet, Danièle Roux, Philippe Lenormand, Stephen Dowd, Stephen Keyse, Jacques Pouysségur, Nuclear translocation of p42/p44 mitogen‐activated protein kinase is required for growth factor‐induced gene expression and cell cycle entry The EMBO Journal. ,vol. 18, pp. 664- 674 ,(1999) , 10.1093/EMBOJ/18.3.664